Federal Circuit Sides with J&J in Patent Battle over Schizophrenia Drug Regimen
By Nafsika Karavida and Lucia Mead Last week, in a significant win for Janssen Pharmaceuticals (a Johnson & Johnson company), the U.S. Court of Appeals for the Federal Circuit (“CAFC”) upheld the district court’s ruling in Janssen Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc., affirming that Teva had failed to...